Position in RPRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$15,274,175
New position
Shares Held
318,411
first reported quarter
Ownership
0.055%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 98.4764973571893.ToString("F0")%
Shared 0.ToString("F0")%
None 1.523502642810707.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Eurizon Capital SGR S.p.A. holds $100,991,251 across 37 Biotechnology names. RPRX ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,509 | $36,397,028 | |
| 2 | INCY |
Incyte Corp
|
210,792 | $19,839,743 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
318,411 | $15,274,175 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,525 | $12,767,876 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,184 | $8,001,760 | |
| 6 | INSM |
INSMED Inc
|
18,473 | $3,020,704 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
11,152 | $629,976 | |
| 8 | MRNA |
Moderna, Inc.
|
8,104 | $411,683 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,274,175 | 318,411 | Shares | Other | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||